240 related articles for article (PubMed ID: 28059023)
1. The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis.
Zhang H; Liu Z; Huang L; Hou J; Zhou M; Huang X; Hu W; Liu Z
Lupus; 2017 Aug; 26(9):952-958. PubMed ID: 28059023
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.
Segarra A; Arredondo KV; Jaramillo J; Jatem E; Salcedo MT; Agraz I; Ramos N; Carnicer C; Valtierra N; Ostos E
Lupus; 2020 Feb; 29(2):118-125. PubMed ID: 31865857
[TBL] [Abstract][Full Text] [Related]
3. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
[TBL] [Abstract][Full Text] [Related]
4. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
5. Remission of refractory lupus nephritis with a protocol including rituximab.
Fra GP; Avanzi GC; Bartoli E
Lupus; 2003; 12(10):783-7. PubMed ID: 14596429
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
8. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
10. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
11. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
Cortés-Hernández J; Ordi-Ros J; Labrador M; Segarra A; Tovar JL; Balada E; Vilardell-Tarres M
Lupus; 2003; 12(4):287-96. PubMed ID: 12729052
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
13. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of lupus nephritis with cyclosporin A.
Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF
QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761
[TBL] [Abstract][Full Text] [Related]
15. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
17. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
Bitencourt Dias C; Pinheiro CC; Malafronte P; Titan S; Alves de Brito G; Gera Abrão J; Dos Santos Silva V; Toledo Barros R; Woronik V
Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
[TBL] [Abstract][Full Text] [Related]
18. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
Gourley MF; Austin HA; Scott D; Yarboro CH; Vaughan EM; Muir J; Boumpas DT; Klippel JH; Balow JE; Steinberg AD
Ann Intern Med; 1996 Oct; 125(7):549-57. PubMed ID: 8815753
[TBL] [Abstract][Full Text] [Related]
19. Prednisone in lupus nephritis: how much is enough?
Ruiz-Irastorza G; Danza A; Perales I; Villar I; Garcia M; Delgado S; Khamashta M
Autoimmun Rev; 2014 Feb; 13(2):206-14. PubMed ID: 24189280
[TBL] [Abstract][Full Text] [Related]
20. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]